Syncom Formulations (India) Ltd
SYNCOMFSyncom Formulations (India) Ltd
SYNCOMF![](https://assets.tickertape.in/sector-icons/health_care.png)
![](https://assets.tickertape.in/sector-icons/smallcap.png)
![](https://assets.tickertape.in/sector-icons/high_risk.png)
Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
60.95 | 6.79 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.93 | 6.39 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Syncom Formulations (India) Limited is a pharmaceutical company that manufactures and markets over 300 pharmaceutical formulations products. It also exports various commodities such as agro and confectionary products and industrial products.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 186.57 | 187.90 | 163.10 | 191.85 | 210.73 | 251.98 | 231.68 | 238.86 | 276.91 | 303.79 | ||||||||||
Raw Materials | 135.20 | 123.14 | 109.61 | 136.66 | 155.32 | 165.51 | 137.23 | 142.07 | 233.76 | 257.19 | ||||||||||
Power & Fuel Cost | 2.69 | 3.01 | 3.40 | 3.63 | 3.93 | 3.84 | 4.38 | 5.31 | ||||||||||||
Employee Cost | 13.61 | 14.33 | 14.77 | 15.21 | 15.80 | 18.24 | 20.73 | 24.44 | ||||||||||||
Selling & Administrative Expenses | 16.57 | 20.03 | 16.43 | 16.90 | 13.76 | 19.79 | 29.71 | 27.31 | ||||||||||||
Operating & Other expenses | -0.74 | 7.92 | 2.85 | 2.53 | -0.04 | -0.62 | 7.59 | 5.22 | ||||||||||||
EBITDA | 19.24 | 19.47 | 16.04 | 16.92 | 21.96 | 45.22 | 32.04 | 34.51 | 43.15 | 46.60 | ||||||||||
Depreciation/Amortization | 3.00 | 3.12 | 3.73 | 4.00 | 4.06 | 4.03 | 3.95 | 4.54 | 4.72 | 4.93 | ||||||||||
PBIT | 16.24 | 16.35 | 12.31 | 12.92 | 17.90 | 41.19 | 28.09 | 29.97 | 38.43 | 41.67 | ||||||||||
Interest & Other Items | 0.14 | 0.36 | 0.30 | 0.25 | 0.61 | 0.48 | 1.93 | 3.40 | 4.47 | 3.75 | ||||||||||
PBT | 16.10 | 15.99 | 12.01 | 12.67 | 17.29 | 40.71 | 26.16 | 26.57 | 33.96 | 37.92 | ||||||||||
Taxes & Other Items | 5.74 | 5.34 | 3.37 | 1.58 | 3.03 | 11.53 | 6.39 | 6.50 | 8.63 | 9.39 | ||||||||||
Net Income | 10.36 | 10.65 | 8.64 | 11.09 | 14.26 | 29.18 | 19.77 | 20.07 | 25.33 | 28.53 | ||||||||||
EPS | 0.13 | 0.14 | 0.11 | 0.14 | 0.18 | 0.37 | 0.24 | 0.22 | 0.34 | 0.30 | ||||||||||
DPS | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.15 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Syncom Formulations (India) Ltd | 68.65 | 6.79 | — |
Sun Pharmaceutical Industries Ltd | 45.08 | 6.43 | 0.75% |
Cipla Ltd | 31.71 | 4.88 | 0.80% |
Torrent Pharmaceuticals Ltd | 70.18 | 16.95 | 0.82% |
Price Comparison
Compare SYNCOMF with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.14%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 9, 2022
Dividend/Share
₹0.03
Ex DateEx Date
Sep 9, 2022
Cash Dividend
Ex DateEx DateSep 21, 2017
Dividend/Share
₹0.02
Ex DateEx Date
Sep 21, 2017
Cash Dividend
Ex DateEx DateSep 22, 2016
Dividend/Share
₹0.02
Ex DateEx Date
Sep 22, 2016
Cash Dividend
Ex DateEx DateSep 16, 2015
Dividend/Share
₹0.02
Ex DateEx Date
Sep 16, 2015
Cash Dividend
Ex DateEx DateSep 18, 2014
Dividend/Share
₹0.02
Ex DateEx Date
Sep 18, 2014
The main equity indices traded with significant losses in mid-afternoon trade. The Nifty dropped below the 24,200 level after hitting the day's high of 24,359.95 in early trade. Nifty Bank shares declined after jumping for four consecutive trading sessions. At 14:25 IST, the barometer index, the S&P BSE Sensex, was down 638.61 points or 0.80% to 79,012.88. The Nifty 50 index slipped 190.50 points or 0.78% to 24,156.50. In the broader market, the S&P BSE Mid-Cap index declined 0.72% and the S&P BSE Small-Cap index fell 0.71%. The market breadth was weak. On the BSE, 1,509 shares rose and 2,320 shares fell. A total of 132 shares were unchanged. Economy: India's CPI inflation in July 2024 stood at 3.54%, which is the lowest since August 2019, according to official data released on Monday, August 12. In the previous month of June 2024, India's retail inflation had stood at 5.08%. Meanwhile, India's IIP recorded a growth of 4.2% in June 2024. The factory output, measured in terms of the Index of Industrial Production (IIP) witnessed a growth of 4% in June 2023. Buzzing Index: The Nifty Bank index declined 1.22% to 49,961.30 the index increased 1.67% in the past four trading sessions. HDFC Bank (down 2.93%), Bandhan Bank (down 1.79%), Bank of Baroda (down 0.98%), Kotak Mahindra Bank (down 0.83%), State Bank of India (down 0.71%), ICICI Bank (down 0.39%), IndusInd Bank (down 0.26%), IDFC First Bank (down 0.22%), Axis Bank (down 0.09%) and Punjab National Bank (down 0.08%) declined. Numbers to track: The yield on India's 10-year benchmark federal paper was up 1.82% to 7.004 as compared with previous close 6.996. In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 83.9700, compared with its close of 83.9725 during the previous trading session. MCX Gold futures for 5 September 2024 settlement shed 0.17% to Rs 70,232. The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.05% to 103.19. The United States 10-year bond yield advanced 0.33% to 3.923. In the commodities market, Brent crude for October 2024 settlement declined 31 cents or 0.38% to $82.30 a barrel. Stocks In Spotlight: Syncom Formulations (India) shed 0.13% after the company reported 73.4% increase in consolidated net profit to Rs 7.63 crore in Q1 FY25 from Rs 4.40 crore in Q1 FY24. Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Campus Activewear fell 1.90% after the company's consolidated net profit declined 19.38% to Rs 25.38 crore in Q1 FY25 as compared with Rs 31.48 crore in Q1 FY24. Revenue from operations fell 4.13% YoY to Rs 339.16 crore during the quarter, amidst muted demand scenario driven by general elections.Powered by Capital Market - Live
Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total expenditure added up to Rs 76.80 crore, up by 43.9% as compared with the same period last year. This was primarily due to higher raw material costs (up 134.1% YoY), higher employee expenses (up 26.5% YoY) and higher other expenses (up 23.9% YoY). Profit before tax in Q1 FY25 stood at Rs 10.10 crore, up by 65.3% from Rs 6.11 crore recorded in Q1 FY24. Syncom Formulations (India) is engaged in the manufacturing and dealing in pharmaceutical drugs and formulations, and trading of commodities. It manufactures and markets a range of pharmaceutical formulations in various dosage forms, such as tablets, capsules, liquids orals, liquid vials and ampoule injections and dry powder injections, ophthalmic preparations, dry syrups and suspensions, ointments, creams, gel, ORS and jelly. Powered by Capital Market - Live
Net profit of Syncom Formulations (India) rose 73.41% to Rs 7.63 crore in the quarter ended June 2024 as against Rs 4.40 crore during the previous quarter ended June 2023. Sales rose 45.82% to Rs 87.26 crore in the quarter ended June 2024 as against Rs 59.84 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales87.2659.84 46 OPM %11.9810.80 - PBDT11.407.21 58 PBT10.106.11 65 NP7.634.40 73 Powered by Capital Market - Live
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 7.62%, vs industry avg of 9.21%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.08% to 0.07%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 17.96%, vs industry avg of 15.17%